Gene Expression Analysis Market
Gene Expression Analysis Market by Product (Reagents, Enzymes, Kits, Gene Chips, PCR, NGS, DNA Microarray), Service (RNA Sequencing, Data Analysis), Application (Drug discovery & Development, Clinical Diagnostics), End User, and Region - Global Forecast to 2031
GENE EXPRESSION ANALYSIS MARKET SIZE, SHARE & GROWTH SNAPSHOT
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
The global gene expression analysis market is projected to grow from USD 4.23 billion in 2026 to USD 5.93 billion by 2031, at a CAGR of 7.0% during the forecast period. The market was valued at USD 4.01 billion in 2025. The growth of the gene expression analysis market is driven by the increasing adoption of transcriptomics technologies and the rising demand for precision medicine, targeted therapies, and RNA-based research. Expanding applications in disease profiling, biomarker discovery, and drug development are accelerating the use of techniques such as PCR, microarrays, and RNA sequencing. Additionally, the growing focus on understanding gene regulation and cellular mechanisms is boosting the demand for advanced analytical platforms, supporting higher adoption of instruments, reagents, and data analysis solutions across the market.
KEY TAKEAWAYS
-
By RegionNorth America accounted for the largest share of the gene expression analysis market in 2025. The growth in this region is driven by strong genomics research activities, advanced healthcare and research infrastructure, high investments in biotechnology, supportive regulatory frameworks, and the presence of leading market players promoting the adoption of advanced gene expression technologies.
-
By OfferingBy offering, the reagents & consumables segment accounted for the largest share of the gene expression analysis market in 2025. This growth is driven by the frequent and recurring use of reagents, kits, and assay components across gene expression workflows, including PCR, microarray, and RNA sequencing applications, ensuring consistent demand across research and clinical settings.
-
By ApplicationBy application, the drug discovery & development segment accounted for the largest share of the gene expression analysis market in 2025. This is attributed to the extensive use of gene expression profiling in target identification, biomarker discovery, and validation processes, which enhances the efficiency and success rate of drug development pipelines.
-
By End UserBy end user, pharmaceutical & biotechnology companies accounted for the largest share of the gene expression analysis market in 2025. This dominance is driven by increasing R&D investments, growing focus on precision medicine, and the widespread adoption of gene expression technologies to support drug discovery, development, and commercialization activities.
-
Competitive LandscapeThermo Fisher Scientific Inc., Illumina, Inc., and Revvity were identified as some of the star players in the gene expression analysis market, given their strong market share and product footprint.
-
Competitive Landscape10X Genomics, Zymo Research Corporation, and Promega Corporation, among others, have distinguished themselves among startups and SMEs by securing strong footholds in specialized niche areas, underscoring their potential as emerging market leaders.
The gene expression analysis market is growing due to the increasing adoption of transcriptomics technologies, rising focus on precision medicine and RNA-based research, expanding use of gene expression profiling in disease diagnostics and drug development, and continuous advancements in high-throughput sequencing and PCR.
TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS
The gene expression analysis market is shifting from conventional gene-level analysis methods toward advanced RNA sequencing and AI-driven transcriptomics platforms for deeper biological insights. Adoption of single-cell and spatial transcriptomics technologies is increasing, enabling high-resolution analysis of gene activity across different cell types and tissues. Additionally, the growing demand for faster, scalable, and high-throughput workflows supported by automated data analysis and cloud-based bioinformatics solutions is accelerating market growth. Furthermore, improved biomarker identification, enhanced understanding of disease mechanisms, increased success in drug development, and better reproducibility of results are driving advancements in this market.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
MARKET DYNAMICS
Level
-
Growing use of gene expression analysis in drug discovery and development
-
Expanding applications in disease research
Level
-
High cost of instruments
-
Complexity of data analysis and interpretation
Level
-
Growing adoption of single-cell analysis technologies
-
Expansion of gene expression analysis in clinical and translational research
Level
-
Lack of standardization
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
Driver: Growing use of gene expression analysis in drug discovery and development
The increasing use of gene expression analysis in drug discovery is a key growth driver. It enables efficient target identification, biomarker discovery, and validation across various stages of drug development. Pharmaceutical and biotechnology companies are increasingly adopting these technologies to support precision medicine and improve therapeutic outcomes. As demand for targeted therapies rises, gene expression profiling is becoming essential in enhancing drug development efficiency and success rates.
Restraint: High cost of instruments
The high cost of gene expression analysis instruments limits market growth, particularly for smaller laboratories. Advanced platforms such as sequencing systems and PCR instruments require significant capital investment, along with ongoing costs for maintenance and consumables. These financial barriers restrict widespread adoption, especially in cost-sensitive regions, and can limit access to advanced technologies.
Opportunity: Growing adoption of single-cell analysis technologies
The rising adoption of single-cell analysis technologies offers strong growth opportunities. These methods enable detailed analysis of gene expression at the individual cell level, providing insights into cellular heterogeneity. Increasing applications in oncology and immunology, along with technological advancements, are driving demand for single-cell gene expression solutions.
Challenge: Lack of standardization
Lack of standardization in workflows and data analysis remains a key challenge. Variations in sample preparation, platforms, and analytical methods can lead to inconsistent results. This limits reproducibility and comparability, especially in clinical applications, highlighting the need for standardized protocols and validation frameworks.
GENE EXPRESSION ANALYSIS MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES
| COMPANY | USE CASE DESCRIPTION | BENEFITS |
|---|---|---|
 |
Single-cell RNA sequencing applied to identify rare drug-resistant cancer stem cells and uncover gene expression heterogeneity in tumor populations | Detection of rare cell populations | Enhanced biomarker discovery | Improved cancer treatment strategies |
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET ECOSYSTEM
The gene expression analysis market ecosystem comprises instrument manufacturers (Illumina, Revvity, Oxford Nanopore Technologies, PacBio), reagent & consumable suppliers (Thermo Fisher Scientific, Bio-Rad Laboratories, QIAGEN, Agilent Technologies), regulatory authorities (US FDA, EMA, MHRA, ANVISA), and end users (Amgen, Novartis, Merck, MIT). Reagent and consumable suppliers provide essential kits, enzymes, probes, and assay components used by manufacturers to develop platforms such as PCR systems, microarrays, and sequencing technologies. Regulatory bodies establish guidelines for data accuracy, validation, and quality standards in research and clinical applications. End users, including pharmaceutical and biotechnology companies as well as research institutions, utilize these solutions for gene expression profiling, biomarker discovery, disease research, and drug development.
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET SEGMENTS
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
Gene Expression Analysis Market, By Offering
In 2024, the reagents & consumables segment dominated the gene expression analysis market. This leadership is driven by their extensive use across workflows such as PCR, microarray, and RNA sequencing. Their recurring consumption in sample preparation, amplification, and analysis ensures steady demand.
Gene Expression Analysis Market, By Application
In 2024, drug discovery & development dominated the gene expression analysis market, supported by the growing use of transcriptomic profiling in pharmaceutical research. These technologies play a critical role in target identification, biomarker discovery, and validation processes.
Gene Expression Analysis Market, By End User
In 2024, pharmaceutical & biotechnology companies dominated the gene expression analysis market due to their strong focus on R&D and increasing investment in advanced genomic technologies. These organizations widely utilize gene expression analysis for drug development, precision medicine, and biomarker research.
GENE EXPRESSION ANALYSIS MARKET: COMPANY EVALUATION MATRIX
In the gene expression analysis market company evaluation matrix, Thermo Fisher Scientific Inc. is positioned as the star player due to its strong presence across gene expression workflows. The company offers a broad range of instruments, reagents, and analysis solutions used in PCR, sequencing, and microarray-based applications. Its global scale, consistent product quality, and wide adoption across research and clinical settings make it a reliable partner for pharmaceutical, biotechnology, and academic organizations. F. Hoffmann-La Roche Ltd. is considered an emerging leader in this market. The company is expanding its presence through advanced molecular diagnostics and gene expression platforms. Its focus on precision medicine, integrated diagnostic solutions, and continuous innovation is supporting increased adoption in both clinical and research applications, strengthening its position in the market.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
KEY MARKET PLAYERS
- Thermo Fisher Scientific Inc. (US)
- Illumina, Inc. (US)
- Revvity (US)
- QIAGEN (Germany)
- Bio-Rad Laboratories, Inc. (US)
- F. Hoffmann-La Roche Ltd (Switzerland)
- PacBio (US)
- Agilent Technologies, Inc. (US)
- Sysmex Corporation (Japan)
- BGI (China)
- Eurofins Scientific (Luxembourg)
- Standard BioTools (US)
- Oxford Nanopore Technologies plc (UK)
- GenScript (US)
- Takara Bio Inc. (Japan)
- Danaher Corporation (US)
- Bruker (US)
MARKET SCOPE
| REPORT METRIC | DETAILS |
|---|---|
| Market Size, 2025 (Value) | USD 4.01 Billion |
| Market Forecast, 2031 (Value) | USD 5.93 Billion |
| Growth Rate | CAGR of 7.0% from 2026–2031 |
| Years Considered | 2024–2031 |
| Base Year | 2025 |
| Forecast Period | 2026–2031 |
| Units Considered | Value (USD Million/Billion) |
| Report Coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments Covered |
|
| Regions Covered | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
WHAT IS IN IT FOR YOU: GENE EXPRESSION ANALYSIS MARKET REPORT CONTENT GUIDE
DELIVERED CUSTOMIZATIONS
We have successfully delivered the following deep-dive customizations:
| CLIENT REQUEST | CUSTOMIZATION DELIVERED | VALUE ADDS |
|---|---|---|
| Rest of Europe Breakdown | Country-level market sizing and growth forecasts (Sweden, Switzerland, Turkey, the Netherlands, Norway, Poland, Portugal, Romania, Denmark, Estonia, Finland, the Czech Republic, Greece, Austria, Belgium, and Russia) | Provides granular country-level insights, enabling clients to prioritize high-growth markets |
| Company Evaluation |
|
Delivers visibility into competitors, helping clients identify partners, evaluate positioning, and detect market gaps for smarter collaboration, outsourcing, and strategic market entry decisions |
RECENT DEVELOPMENTS
- October 2025 : Thermo Fisher launched the Applied Biosystems SwiftArrayStudio Microarray Analyzer, designed for sample analysis. In conjunction with two new arrays (Applied Biosystems Axiom PharmacoPro Array and the Applied Biosystems Axiom PangenomePro Array), the analyzer combined four genotyping processes into a single, integrated device.
- October 2025 : Thermo Fisher announced a research and development (R&D) partnership with AstraZeneca BioVentureHub, focusing on chromatography, molecular genomics, and proteomics.
- July 2025 : Illumina Inc. launched the next generation of TruSight Oncology 500, its cancer research assay that enables comprehensive genomic profiling.
Table of Contents
Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.
Methodology
This research study extensively utilized secondary sources, directories, and databases to identify and collect valuable information for analyzing the global gene expression analysis market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative & quantitative information and assess the growth prospects of the market. The global market size estimated through secondary research was triangulated with inputs from primary research to determine the final market size.
Secondary Research
Secondary research was primarily used to identify and collect information for the comprehensive technical, market-oriented, and commercial study of the gene expression analysis market. The secondary sources used for this study include World Health Organization (WHO), Food and Drug Administration (FDA), National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), Environmental Protection Agency (EPA), European Medicines Agency (EMA), Biotechnology Innovation Organization (BIO), International Society for Pharmaceutical Engineering (ISPE), National Institute for Health and Care Excellence (NICE), World National Center for Biotechnology Information (NCBI), International Trade Centre, Journal of Molecular Biology, Journal of Biological Chemistry (JBC), American Association for Cancer Research (AACR), the American Society of Human Genetics (ASHG), and the European Molecular Biology Organization (EMBO). Academic Journals and Company Websites, corporate & regulatory filings, such as annual reports, SEC filings, investor presentations, and financial statements; business magazines & research journals; press releases; and trade, business, and professional associations, among others.
Secondary data were collected and analyzed to determine the overall size of the global gene expression analysis market, which was subsequently validated through primary research. These sources were also used to gather key information about major players, market classification, and segmentation based on industry trends, regional/country-level markets, market developments, and technological perspectives.
Primary Research
In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative & quantitative information and assess the market’s prospects. Various primary sources from the supply & demand sides of the market were interviewed to obtain qualitative and quantitative information.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The top-down and bottom-up approaches were used to estimate & validate the total size of the gene expression analysis market. These methods were also used extensively to estimate the size of various market segments.
Gene Expression Analysis Market : Top-Down and Bottom-Up Approach
Data Triangulation
After evaluating the overall market size through the market size estimation process, the total market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were used, whenever applicable, to complete the overall market engineering process and obtain precise statistics for all segments and subsegments. The data was triangulated by analyzing various factors and trends from the demand and supply sides.
Market Definition
Gene expression analysis is the systematic investigation of the activity levels of genes within a cell, tissue, or organism at a specific point in time, which involves measuring & quantifying the production of RNA or protein molecules encoded by genes that reflect the degree to which genes are being transcribed and translated into functional products. In gene expression analysis, we use products & services related to the analysis and measurement of gene expression. This market includes gene expression analysis products & services such as reagents & consumables, instruments, gene expression analysis services, and bioinformatics solutions.
Key Stakeholders
- Pharmaceutical & biotechnology companies
- Contract research organizations (CROs)
- Life science companies
- Academic & research institutes
- Private research institutes
- Venture capitalists & investors
- Market research & consulting firms
- Government associations
- Medical institutions & universities
- Hospitals & clinics
Report Objectives
- To define, describe, and forecast the gene expression analysis market based on offering, application, end user, and region
- To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
- To strategically analyze micromarkets concerning individual growth trends, prospects, and contributions to the overall gene expression analysis market
- To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments concerning six main regions, namely, North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
- To strategically profile the key players in the gene expression analysis market and comprehensively analyze their core competencies and market rankings
- To track and analyze competitive developments such as product launches, acquisitions, expansions, agreements, partnerships, and collaborations in the gene expression analysis market
- To benchmark players within the gene expression analysis market using the ‘Company Evaluation Matrix’ framework, which analyzes market players based on various parameters within the broad categories of business and product/service strategy
Customization Options
With the given market data, MarketsandMarkets offers customizations per the company’s specific needs. The following customization options are available for this report:
Geographical Analysis
- Further breakdown of the Rest of Europe gene expression analysis market, by country
- Further breakdown of the Rest of Asia Pacific gene expression analysis market, by country
- Further breakdown of the Rest of Latin America gene expression analysis market, by country
- Further breakdown of the Rest of Middle East gene expression analysis market, by country
Company Information
- Detailed analysis and profiling of additional market players (up to five)
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This ReportPersonalize This Research
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
Let Us Help You
- What are the Known and Unknown Adjacencies Impacting the Gene Expression Analysis Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Custom Market Research Services
We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements
Get 10% Free Customisation
Still Researching the
Gene Expression Analysis Ecosystem?
See the competitors, opportunities, and growth signals shaping it - instantly.
Generate 15+ consulting-grade strategic insights tailored to your growth question.
Growth opportunities and latent adjacency in Gene Expression Analysis Market